Altoida
Founded 2016 · 29 employees on LinkedIn · 8 known investors
Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease. It serves healthcare providers and pharmaceutical companies for cognitive diagnostics, clinical trial enrichment, and disease progression research in the neurological care field.
Investors · 8
Alpana VenturesGeneva
Eisai Innovation, Inc.San Francisco
Hikma VenturesLondon · $5M
M VenturesLos Angeles · $10.8M
Polytech Ecosystem Ventures
VI PartnersAltendorf · $2.2M – $4.5M
Whitecap Venture PartnersToronto · $1.5M – $3.6M
Also in the syndicate · 1
Merck KGaAlead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AMar 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
3 people who came through Altoida went on to found or lead other companies.
In the news
Frequently asked questions
- What does Altoida do?
- Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease. It serves healthcare providers and pharmaceutical companies for cognitive diagnostics, clinical trial enrichment, and disease progression research in the neurological care field.
- Who are Altoida's investors?
- Altoida's investors include Alpana Ventures, Eisai Innovation, Inc., Hikma Ventures, M Ventures, Polytech Ecosystem Ventures, VI Partners, Whitecap Venture Partners.